Pharmacogenetics has evolved over the past few years into pharmacogenomics, shifting focus from individual candidate genes to genome-wide association studies. The latest installment in our Genomic Medicine series, Genomics and Drug Response, reviews recent pharmacogenetic and pharmacogenomic advances, and discusses how such advances are reflected in drug labels. The authors aim to provide assurance that advances resulting from the application of genomic science to drug therapy may assist with drug selection and dosing, and reduce the odds of adverse drug reactions. Earlier articles in this series include Genomics and the Continuum of Cancer Care — NEJM, Genomics, Type 2 Diabetes, and Obesity, Ancestry and Disease in the Age of Genomic Medicine, New Therapeutic Approaches to Mendelian Disorders, Genomewide Association Studies and Assessment of the Risk of Disease, Genomic Medicine — An Updated Primer.
Posted by Karen Buckley • April 6th, 2011
Comments are closed.
Get Our Blog Updates Via E-mail!
NEJM in the News
- The Washington Post covered the NEJM Perspective, “Zika and the Risk of Microcephaly.” STAT, U.S. News & World Report/AP, and the New York Times/AP also covered the article. (May 25)
- HealthDay covered the NEJM Original Articles, “A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A” and “Factor VIII–Mimetic Function of Humanized Bispecific Antibody in Hemophilia A.” U.S. News & World Report ran the HealthDay story. (May 25)
- HealthDay covered the NEJM Original Article, “Exome Sequencing and the Management of Neurometabolic Disorders.” ScienceDaily also covered the article. U.S. News & World Report ran the HealthDay story. (May 25)
- The Washington Post mentioned NEJM in a story titled, “7 things about vaccines and autism that the movie ‘Vaxxed’ won’t tell you.” The story also references a 2010 paper that was retracted by the Lancet. (May 25)
- Undark referenced the 2013 NEJM Perspective, “The National Children’s Study — A Proposed Plan,” and the 2015 Perspective, “The National Children’s Study — End or New Beginning?” in a story titled, “The Death of a Study.” (May 25)
- The Huffington Post mentioned NEJM in a story titled, “Why Was the Study Finding 250,000 USA Medical Deaths Published in a British Journal?” (May 24)
NEJM on Youtube
- NEJM Group will be exhibiting at the upcoming conferences below:
- European Society of Cardiology in London, England. Aug. 29-Sept. 2. Booth #C-807
- IDWeek in San Diego, CA. Oct. 8-10. Booth #922
- American Society of Nephrology in San Diego, CA. Nov. 5-7. Booth #508
- American Heart Association in Orlando, FL. Nov. 8-10. Booth #822
- American Society of Hematology in Orlando, FL. Dec. 5-7. Booth #514
Tagsabdominal pain anemia asthma breast cancer cancer cardiac arrest Case Records Case Records of the Massachusetts General Hospital chemotherapy Clinical Decisions Clinical Practice Clinical Problem-Solving colorectal cancer COPD CPR Diabetes dyspnea fever global health glucocorticoids HIV hypertension Interactive Medical Cases Massachusetts General Hospital medicine myocardial infarction NEJM nejm 200th anniversary NEJM 200th Anniversary website NEJM Group NEJM Group Open Forum New England Journal of Medicine obesity pregnancy primary care/hospitalist/clinical practice prostate cancer pulmonary embolism septic shock smoking stroke surgery thrombocytopenia tuberculosis type 2 diabetes Venous thromboembolism